Page last updated: 2024-12-11

gw 311616

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

GW 311616: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9800961
CHEMBL ID2367812
SCHEMBL ID6620439
MeSH IDM0305714

Synonyms (24)

Synonym
CHEMBL2367812
SCHEMBL6620439
CS-3126
gw311616
HY-15891
pyrrolo(3,2-b)pyrrol-2(1h)-one, hexahydro-3-(1-methylethyl)-1-(methylsulfonyl)-4-((2e)-1-oxo-4-(1-piperidinyl)-2-buten-1-yl)-, (3s,3as,6ar)-
l8012v52pn ,
pyrrolo(3,2-b)pyrrol-2(1h)-one, hexahydro-3-(1-methylethyl)-1-(methylsulfonyl)-4-((2e)-1-oxo-4-(1-piperidinyl)-2-butenyl)-, (3s,3as,6ar)-
pyrrolo(3,2-b)pyrrol-2(1h)-one, hexahydro-3-(1-methylethyl)-1-(methylsulfonyl)-4-(1-oxo-4-(1-piperidinyl)-2-butenyl)-, (3s-(3alpha,3aalpha,4(e),6abeta))-
unii-l8012v52pn
gw-311616
198062-54-3
(+)-gw-311616
pyrrolo(3,2-b)pyrrol-2(1h)-one, hexahydro-3-(1-methylethyl)-1-(methylsulfonyl)-4-(1-oxo-4-(1-piperidinyl)-2-butenyl)-, (3s-(3.alpha.,3a.alpha.,4(e),6a.beta.))-
AKOS030526697
(3ar,6s,6as)-4-methylsulfonyl-1-[(e)-4-piperidin-1-ylbut-2-enoyl]-6-propan-2-yl-3,3a,6,6a-tetrahydro-2h-pyrrolo[3,2-b]pyrrol-5-one
NCGC00390674-01
BCP11029
Q27282819
MS-26715
A925045
(3s,3as,6ar)-3-isopropyl-1-(methylsulfonyl)-4-((e)-4-(piperidin-1-yl)but-2-enoyl)hexahydropyrrolo[3,2-b]pyrrol-2(1h)-one
gw 311616
BG168512

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency26.83700.01237.983543.2770AID1645841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID28486Second-order rate constant (M-1 s-1) for the alkaline hydrolysis in water at 30 degrees C2002Journal of medicinal chemistry, Jun-20, Volume: 45, Issue:13
Acylating agents as enzyme inhibitors and understanding their reactivity for drug design.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's4 (33.33)29.6817
2010's4 (33.33)24.3611
2020's3 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]